title: The effects of bone therapy on tibial bone loss in young women with anorexia nervosa.
abstract: OBJECTIVE
  Osteoporosis is recognized as a common medical complication of anorexia nervosa (AN). The purpose of the current study was to investigate the recovery mechanism of osteoporosis in AN and the effect of medical treatment on the skeletal system.
  
  
  METHODS
  We conducted a randomized placebo-controlled study of the effects of etidronate and calcium and vitamin D on bone loss in 41 outpatients with the restricting type of AN (AN-R). We measured the tibial speed of sound (SOS) before and after 3 months of treatment.
  
  
  RESULTS
  The bone mineral density (BMD) of the tibial SOS change in both the etidronate group and the calcium and vitamin D Group was significantly greater (p < .001) than in the control group. Urine-N-telopeptide cross-links of type I collagen (NTx) before and after treatment decreased significantly (p < .01) in the etidronate group.
  
  
  CONCLUSIONS
  These findings suggest that both etidronate and calcium and vitamin D are equally efficacious for reversing the degree of osteoporosis in patients with AN.
authors.affiliation: Department of Behavioral Medicine, Kagoshima University Graduate School of Medical and Dental Science, Kagoshima-City, Japan. ayana-n@m3.kufm.kagoshima-u.ac.jp
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Nakahara
authors.forename: Nobuatsu
authors.initials: N
authors.lastname: Nagai
authors.forename: Muneki
authors.initials: M
authors.lastname: Tanaka
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Muranaga
authors.forename: Shinya
authors.initials: S
authors.lastname: Kojima
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Nozoe
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Naruo
mesh_terms: D000328:Adult; D000856:Anorexia Nervosa / Q000150:complications*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D013977:Tibia / Q000187:drug effects* / Q000473:pathology*; D014807:Vitamin D / Q000627:therapeutic use*
chemical_list: D050071:Bone Density Conservation Agents; D014807:Vitamin D; D012968:Etidronic Acid; D002118:Calcium